Clinical Trial To Evaluate The Effect Of Valsartan On Insulin Sensitivity In Subjects With Impaired Glucose Tolerance
NCT00241072
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Impaired Glucose Tolerance
Interventions
DRUG:
valsartan
Sponsor
Novartis